Brunswick Exploration to Begin a Lithium Exploration Initiative in the Kingdom of Saudi Arabia GlobeNewswire November 24, 2025 MONTREAL, Nov. 24, 2025 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company“) is pleased to announce that it has identified the Kingdom of Saudi Arabia (the “KSA” or “Saudi Arabia“) […]

Ocular Therapeutix(TM) Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI(TM) in NPDR GlobeNewswire November 24, 2025 First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI's registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global, complementary superiority trials using a novel ordinal diabetic retinopathy

Calian Awarded Contract to Deliver Four Ka/Q/V-Band Gateways for Two Geostationary Satellites Contract will enable secure, high-capacity government communications across three continents GlobeNewswire November 24, 2025 OTTAWA, Ontario, Nov. 24, 2025 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a trusted provider of mission-critical solutions for defence, space, healthcare, and other critical infrastructure sectors, today

Vaxil Announces Update on Non-Brokered Private Placement GlobeNewswire November 24, 2025 Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company“) (TSX VENTURE: VXL) is pleased to announce that the Company, further to it's news release from October 29, 2025,

Kymera Therapeutics to Participate in Upcoming December Investor Conferences GlobeNewswire November 24, 2025 WATERTOWN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the

Biomea Fusion to Participate at Upcoming Investor Conferences GlobeNewswire November 24, 2025 SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in the upcoming investor conferences: Piper Sandler 37th Annual Healthcare

Village Farms Launches Promenade Brand's First Vape in Quebec Introduction of Promenade Matin vape marks a new era for regulated cannabis vaping products in Quebec GlobeNewswire November 24, 2025 HUNTINGDON, Quebec, Nov. 24, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (Nasdaq: VFF), together with its Quebec-based subsidiary Rose LifeScience Inc., today announced the launch

Hollywood Racks Announces Two New Accessories for its CrossTrack Series The Bike Add-On Kit and LED Light Bar are designed to enhance CrossTrack bike racks GlobeNewswire November 24, 2025 Los Angeles, CA, Nov. 24, 2025 (GLOBE NEWSWIRE) — Hollywood Racks, the family-owned California brand known for Simple – Strong – Secure.(TM) bike racks, is proud

Sionna Therapeutics to Participate in Upcoming December Investor Conferences GlobeNewswire November 24, 2025 WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis

Aldebaran Files PEA on Sedar+ and Announces Termination of the Option Agreement with Nuton Holdings Ltd. GlobeNewswire November 24, 2025 VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (“Aldebaran” or the “Company“) (TSX-V: ALDE, OTCQX: ADBRF) is pleased to announce the filing on SEDAR+ of an updated Technical Report and Preliminary